KetteRx GmbH is a Basel based company active in the field of creating, planning and operating biotech companies. The founders, two former Roche Pharma Partnering alumni and experienced dealmakers, Alexander Breidenbach, a drug development expert and Michael Motz, a chemist by training, have teamed up to scout for innovative scientific ideas and assets addressing unmet medical needs. We collaborate with the inventors to drive development of these projects with a pharma industry point of view. We lead the company creation tasks with the aim to become an investible entity for venture capital investors. Together, we will take care of securing funding and subsequent execution by leading the company operations up to a potential exit. KetteRx operates in close collaboration with large investors and acts as Entrepreneurs-in-Residence for BB Pureos Bioventures.